Claritev (CTEV) Stock Overview
Provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
CTEV Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Claritev Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$17.71 |
| 52 Week High | US$74.07 |
| 52 Week Low | US$12.04 |
| Beta | 0.68 |
| 1 Month Change | -31.81% |
| 3 Month Change | -47.84% |
| 1 Year Change | -9.18% |
| 3 Year Change | -58.62% |
| 5 Year Change | -93.01% |
| Change since IPO | -95.45% |
Recent News & Updates
Recent updates
Claritev Corporation (NYSE:CTEV) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
Jan 18
Claritev: The Middleman In A Vertically Integrated Market
Jan 14Improved Revenues Required Before Claritev Corporation (NYSE:CTEV) Stock's 35% Jump Looks Justified
Nov 01Claritev Corporation's (NYSE:CTEV) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Sep 09Claritev (NYSE:CTEV) Use Of Debt Could Be Considered Risky
Jul 30Claritev Corporation's (NYSE:CTEV) Price Is Right But Growth Is Lacking After Shares Rocket 25%
Jul 09
AI And Global Partnerships Will Reshape Personalized Medicine
AI-powered analytics, digital transformation, and global expansions position Claritev to monetize higher-value healthcare solutions and tap into growing, aging populations.Claritev Corporation (NYSE:CTEV) Shares Fly 30% But Investors Aren't Buying For Growth
May 15Little Excitement Around Claritev Corporation's (NYSE:CTEV) Revenues As Shares Take 28% Pounding
Mar 20There's No Escaping MultiPlan Corporation's (NYSE:MPLN) Muted Revenues Despite A 29% Share Price Rise
Feb 03MultiPlan Corporation (NYSE:MPLN) Stock Catapults 28% Though Its Price And Business Still Lag The Industry
Dec 20Here's Why MultiPlan (NYSE:MPLN) Is Weighed Down By Its Debt Load
Dec 13MultiPlan Corporation (NYSE:MPLN) Shares Fly 55% But Investors Aren't Buying For Growth
Oct 20MultiPlan Corporation (NYSE:MPLN) Not Doing Enough For Some Investors As Its Shares Slump 40%
Aug 18Little Excitement Around MultiPlan Corporation's (NYSE:MPLN) Revenues As Shares Take 46% Pounding
Jul 04MultiPlan (NYSE:MPLN) Use Of Debt Could Be Considered Risky
Jul 02MultiPlan Corporation (NYSE:MPLN) Looks Inexpensive After Falling 29% But Perhaps Not Attractive Enough
May 09Estimating The Intrinsic Value Of MultiPlan Corporation (NYSE:MPLN)
Apr 23Why Investors Shouldn't Be Surprised By MultiPlan Corporation's (NYSE:MPLN) 26% Share Price Plunge
Mar 13MultiPlan (NYSE:MPLN) Has A Somewhat Strained Balance Sheet
Mar 05Shareholder Returns
| CTEV | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 25.0% | 6.5% | -1.2% |
| 1Y | -9.2% | -31.4% | 17.6% |
Return vs Industry: CTEV exceeded the US Healthcare Services industry which returned -31.4% over the past year.
Return vs Market: CTEV underperformed the US Market which returned 17.6% over the past year.
Price Volatility
| CTEV volatility | |
|---|---|
| CTEV Average Weekly Movement | 18.2% |
| Healthcare Services Industry Average Movement | 8.5% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in US Market | 16.1% |
| 10% least volatile stocks in US Market | 3.2% |
Stable Share Price: CTEV's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: CTEV's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | 3,000 | Travis Dalton | www.claritev.com |
Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services.
Claritev Corporation Fundamentals Summary
| CTEV fundamental statistics | |
|---|---|
| Market cap | US$294.97m |
| Earnings (TTM) | -US$284.28m |
| Revenue (TTM) | US$965.41m |
Is CTEV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CTEV income statement (TTM) | |
|---|---|
| Revenue | US$965.41m |
| Cost of Revenue | US$253.41m |
| Gross Profit | US$712.00m |
| Other Expenses | US$996.28m |
| Earnings | -US$284.28m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -17.17 |
| Gross Margin | 73.75% |
| Net Profit Margin | -29.45% |
| Debt/Equity Ratio | -2,752.2% |
How did CTEV perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/05 23:54 |
| End of Day Share Price | 2026/03/05 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Claritev Corporation is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Steven Valiquette | Barclays |
| Andrew D'Silva | B. Riley Securities, Inc. |
| Daniel Grosslight | Citigroup Inc |